Applied DNA Sciences (APDN) 10-Q2024 Q1 Quarterly report

Filed: 8 Feb 24, 4:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: absorb, agent, bacterial, bid, byproduct, capable, carbon, catalyzed, chance, committee, concept, concurrent, CY, deducting, delisting, discretionary, Distribution, double, downstream, dropped, event, fiber, fit, Food, foregoing, globally, GMP, Group, half, hydrogen, immunogenic, intangible, intramuscular, Judith, LineaDNA, Maxim, monitor, month, Murrah, nascent, NY, oxygen, partnership, pharmaceutical, pharmaceutically, placement, problematic, promulgated, proof, purpose, refine, registered, reliance, resale, resign, Rule, Shareholder, shelf, stranded, substance, suitable, TAM, temporary, thereunder, unclear, voluntarily, waiting, waive, written

Removed: adaptable, audit, authorization, automated, backed, cGMP, clear, CLEP, combination, committed, community, complied, conditionally, conform, consult, convincing, Costco, customizable, deficiency, deficit, depending, detected, developed, digital, discovery, disruptive, economically, effectively, emergency, enacted, entirety, environment, Exhibit, feasible, final, foreign, greatly, HDR, highly, home, Hospital, identifying, implementation, implementing, importer, improve, indirect, infection, ingredient, integrity, investing, LDT, leather, longer, maintain, maintaining, marketing, marking, misstatement, mitigate, Monkeypox, national, newly, ongoing, operated, opportunistic, originated, personnel, pooled, pooling, positivity, presumption, prevented, priority, Program, pursue, pursuing, quickly, rebuttable, recovery, relevance, remediated, remediation, repair, replicate, request, restatement, resulted, retail, return, review, run, sample, scalable, scheduling, school, size, software, solution, spread, strong, supportable, tax, textile, throughput, track, translation, turnkey, typically, undergoing, University, vaccine, vary, vest, workflow, workplace

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated APDN transcripts

APDN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Beth Jantzen, Chief Financial Officer of Applied DNA Sciences, Inc. (the “Company”), in connection with the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2023 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, hereby certifies pursuant to the requirements of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that

·	the Report fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934, and

·	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification is being provided pursuant to 18 U.S.C. 1350 and is not to be deemed a part of the Report, nor is it to be deemed to be “filed” for any purpose whatsoever.

	By:	/s/ BETH JANTZEN
		Beth Jantzen, CPA
		Chief Financial Officer
		(Principal Financial Officer)
		Dated: February 8, 2024